Pain Drugs against Shingles Disappoint Patients; CBCD Reviews the Medical Evidence

Industry: Health & Fitness

Ineffective drugs are a problem since up to 5% of the population experiences intense pain associated with herpes zoster (VZV). (1) CBCD highlights effective VZV remedies.

New York (PRUnderground) August 13th, 2014

“Infected with the Varicella Zoster Virus (VZV)? The CBCD recommends taking Novirin or Gene-Eden-VIR.” – Greg Bennett, CBCD

Patients who develop shingles experience intense pain. This extreme pain is called post-herpetic neuralgia (PHN), and it is the most common symptom of herpes zoster (shingles). (1) Dr. Casale and colleagues wrote that this pain is experienced “as a direct consequence of a lesion or a disease affecting the somatosensory system.” (2) Dr. Casale is from the Department of Clinical Neurophysiology and Pain Rehabilitation Unit, in Pavia, Italy. This pain can considerably affect quality of life for patients. (2)  Despite the fact that up to 5% of the population develops PHN, “treatment of neuropathic pain (post herpetic neuralgia) continues to be challenging due to the inadequate effectiveness of systemic therapies and their frequent central side effects.” (2) In other words, drugs against pain, which work on the whole body, are largely ineffective against PHN. The CBCD believes this is why people need a remedy that targets the latent Varicella Zoster Virus (VZV) that causes Shingles.

“Herpes zoster (HZ), commonly called shingles, is a distinctive syndrome caused by reactivation of varicella zoster virus (VZV). This reactivation happens whenever immunity to VZV declines as a result of aging or immunosuppression (a damaged immune system). Herpes zoster will happen at any age yet commonly affects the elderly population. Postherpetic neuralgia (PHN), defined as pain persisting over 3 months.” (See Mayo Clinic Proceedings, from March 2009) (3) The CBCD points out that when the immune system is damaged, a latent virus, such as VZV, can increase in number, causing shingles and post-herpetic neuralgia.

Click to learn more about latent viruses.

The CDC notes that “Nearly 1 out of every 3 people in the United States will develop shingles in their lifetime. Anyone who has had chickenpox or received chickenpox vaccine in the past may develop shingles.” (See CDC, last updated May 1, 2014) (4)

The CBCD recommends that people who have had chickenpox in the past take Novirin or Gene-Eden-VIR. The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against herpes viruses (like VZV), and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs.  Study authors wrote that, “individuals infected with a (latent virus) … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (5)  The study authors also wrote that, “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (5)

Both products can be ordered online on the Novirin and Gene-Eden-VIR websites.

Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.

How long does Shingles pain last?

“In most cases, the rash and pain (of Shingles) lasts two to four weeks, but up to one person in five develops postherpetic neuralgia. The pain can be intense and has been described as a burning or stabbing sensation, in some cases feeling like an electric shock. Many people with postherpetic neuralgia make a full recovery within a year, but in some cases the nerves do not heal completely and symptoms last for several years or permanently.” (See Neurology, from July, 2014) (6) Moreover, while most people respond to medications, including tricyclic antidepressants, anti-epileptic drugs or opioids to reduce the pain, 40 to 50 per cent only partially respond. (6) This is why people need a remedy that targets the latent virus that causes Shingles.

Based on the evidence presented above, the CBCD recommends that individuals take Novirin or Gene-Eden-VIR, two natural antivirals designed to help boost the immune system target latent viruses.

Learn more about Novirin and latent viruses, and Gene-Eden-VIR and latent viruses.

References:

(1) Casale R1, Di Matteo M2, Minella CE3, Fanelli G4, Allegri M5 Reduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case series. J Pain Res. 2014 Jun 23;7:353-7

http://www.ncbi.nlm.nih.gov/pubmed/25018649

(2) Patient.co.uk – Postherpetic Neuralgia. Last checked on February 5, 2013.
http://www.patient.co.uk/doctor/postherpetic-neuralgia-pro

(3) Priya Sampathkumar, MD, Lisa A. Drage, MD, and David P. Martin, MD, PhD Herpes Zoster (Shingles) and Postherpetic Neuralgia. Mayo Clinic Proceedings. March 2009.

ncbi.nlm.nih.gov/pmc/articles/PMC2664599/

(4) CDC – Shingles (Herpes Zoster). Last updated May 1, 2014.

cdc.gov/shingles/about/symptoms.html

(5) Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8

http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101#.U-c7EeOSz90

(6) Breuer J1, Pacou M2, Gautier A2, Brown MM2. Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK. Neurology. 2014 Jul 8;83(2):e27-33.

ncbi.nlm.nih.gov/pubmed/25002574

 

About CBCD

About CBCD

The Center for the Biology of Chronic Disease (http://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases. The CBCD first published Dr. Hanan Polansky’s highly acclaimed “Purple” book, entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” in 2003. In this book, he explains how foreign DNA fragments can cause many major diseases. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Become a Fan

Press Contact

Name
Mike Evans
Phone
585-250-9999
Email
note
84cefeb4cb4f944827ee5398f4d7ec69
@buy-gene-eden.com
Website
http://www.gene-eden-vir.com

Video

Website